Fr
Contact us
Science
Cell Expansion
and Engineering Platform
ExCellThera’s robust cell expansion and engineering platform is based on three pillars of excellence.

The company’s technology platform is based on a pipeline of proprietary molecules with strong patent positions. Its know-how in cell manufacturing has made it a leader in effective and robust stem cell expansion. ExCellThera is also leveraging its cell engineering expertise to further optimize its platform.

Pipeline of Proprietary Molecules with Strong Patent Positions
UM171 Series
UM092 Series
Fr
Contact us
Science
Pipeline

Program

Cell Line

Ownership/
product

Indication

Discovery

Pre-Clinical

Phase I

Phase 2

Phase 3

HSCT

Cord Blood HSCs

ECT-001-CB

Allo HSCT

Mobilized Blood/
Bone Marrow HSCs

ECT-001-mPB

ECT-001-BM

Allo & Auto
HSCT

Engineered HSCs
(eHSCs)

ECT-002

Allo & Auto
HSCT

Solid Organ
Tolerization

Bone Marrow

HSCs

+ collaborators

Solid Organ
Transplants

iPSC

Pluripotent Stem

Cells (PSCs)

Out-licence
& supply

PSC Related
Programs

Gene Therapy

Transduced

HSCs

+ collaborators

Gene
Therapy

HSCT

Cell Line

Ownership/
product

Indication

Cord Blood HSCs

ECT-001-CB

Allo HSCT

Phase 3

Mobilized

Blood/Bone

Marrow HSCs

ECT-001-mPB
ECT-001-BM

HSCT Allo & Auto

Pre-Clinical

Engineered

HSCs (eHSCs)

ECT-002

HSCT Allo & Auto

Pre-Clinical

Solid organ tolerization

Bone Marrow HSCs

+ collaborators

Solid Organ
Transplants

Pre-Clinical

iPSC

Pluripotent

Stem Cells (PSCs)

Out-licence
& supply

PSC Related
Programs

Pre-Clinical

Gene Therapy

Transduced

HSCs

+ collaborators

Gene
Therapy

Phase I